Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
Sahlgrenska University Hospital · Thrombosis Research Institute · +10 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
983
total citations
- FWCI
- 54.14
- Percentile
- 100%
- References
- 19
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Medicine
- Dabigatran
- Direct thrombin inhibitor
- Randomized controlled trial
- Anesthesia
- Incidence (geometry)
- Knee replacement
- Venous thromboembolism
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.